China Aoyuan and Aoyuan Health Delay Release 2022 mid -term financial report

21st Century Business Herald reporter Wu Shuying Guangzhou reports

On the evening of August 31, 2022, China Aoyuan announced that its nuclearian was still preparing the 2021 results. In view of the release of the annual performance of 2021 and the release of the 2021 annual report, it is expected that the mid -term performance in 2022 and the mid -term report of the 2022 will not be published on time in accordance with the requirements of the listing rules.

China Aoyuan stated in the announcement that the board of directors and corporate management will continue to work closely with its audit institutions, and will publish 2021 annual results as soon as possible under actual feasibility circumstances, and the 2021 annual report and the mid -term report of 2022.

As an out -of -housing company, China Aoyuan currently has no further news in terms of debt restructuring. In terms of delivery, China Aoyuan currently has many cooperation with Greentown.

On August 31, 2022, China Aoyuan and Greentown Real Estate signed a strategic cooperation agreement in Guangzhou. The two parties will carry out deep friendly cooperation such as the construction of Aoyuan Peak and Chongqing Nanchuan Aoyuan Park 1. In July of this year, China Olympic Garden and Greentown's first cooperation project landed in Guangzhou Yunhe Mansion.

On the same day, the Health of Olympic Garden, a subsidiary of China Aoyuan, also said that the Independent Investigation Commission has hired an investigation company to investigate the matters and allegations of funding. Okanyi Health has been actively cooperating with the investigation company. As of the announcement date, the investigation company is still conducting investigations and reporting reports on the results.

In view of this situation, due to the failure of the annual performance in 2021, the mid -term performance in 2022 cannot be published on time. Olympic Health also stated that it will continue to cooperate with and assist the investigation institutions to publish the annual performance report of 2021 as soon as possible under feasible circumstances and the mid -term performance report in 2022.

The Olympic Health Institute refers to the assistance to investigate. On May 3, 2022, the independent investigation committee established by Aoyuan Health hired an international accounting firm to investigate its funds between China Okiyuan and an executive director of the controlling shareholder. contacts. The committee is composed of three independent non -executive directors of the company and has hired Hong Kong lawyers as an independent legal adviser.

In the time of the announcement, Aoyuan Health said that in the process of reviewing the annual performance of 2021, its audit committee received a letter from the audit agency Deloitte, which listed several funds between Olympic Health controlling shareholders Matters, and put forward several suggestions to the review committee on the issue of funding, asking the Olympic Health Board of Directors to know the shareholders and potential investors' funds for the shareholders and potential investors.

Several matters that are listed in the letters include the healthy bank loan contracts of Okiyuan, and the amount of bank loan was shown to 300 million yuan instead of 3 billion yuan. Provide a total financial guarantee for the parent company with a total amount of 4 billion yuan; and the unprecedented bank loan of 500 million yuan between the indirect non -full -funded subsidiary Le Life Smart Community Service Group Branch and the Jiu Tai Rural Commercial Bank.

On June 2, 2022, Aoyuan Health Announcement stated that due to the do not agree with the issues of Deloitte's funding and the above allegations, the additional audit fee required for the annual performance of 2021, Deloitte's resignation of the audit agency, Deloitte's post, Deloitte, It will take effect from May 31, 2022.

In the announcement at the time, October's health emphasized that he did not know the identity of anonymous reports and a reporter who made allegations. The board of directors also said that the allegations were completely false and violated basic business common sense, and lacked the company's lack of basic understanding. The company makes the strongest denial of allegations.

However, after receiving the above letter, Aoyuan Health has also hired the investigation company to further expand the scope of the investigation according to Deloitte's advice, in order to clarify the facts on the situation of allegations.

While the announcement of Yanfa's midterm of 2022, Okiyuan Health also announced that Zheng Wei resigned for other affairs and will no longer serve as executive directors and presidents, which will take effect from September 1, 2022.

Zheng Wei joined the Olympic Garden in June 2020 and served as a senior management of Oasisians and Aoyuan Technology. After that, he was transferred to Aoyuan Health. At the time, Zheng Wei will use his rich experience in the field of information technology to help Ozuya develop a smart community, as well as smart property management services and commercial operation services. Zheng Wei was appointed as the president of Aoyuan Health on January 27, 2021, and was responsible for overall management and operation of comprehensive management and operation. So far, it has only been more than a year and a half.

China Aoyuan and Aoyuan Health are still suspending.

According to the re -trading guidelines received by Olympic Garden in China, it needs to release all the financial results that have not been published in accordance with the listing regulations and handle any review and modification. Relevant reasonable questions; finally, prove that the company complies with the relevant provisions of the listing rules to publish all important information to the market for shareholders and investors to evaluate the company's condition.

The re -trading guidelines received by Aoyuan Health earlier include all unpublished financial performance and processing of any audit revision; appropriate independent law surveys on funding and allegations, announced the results of the investigation and adopting appropriate remedial measures. In addition, an independent internal monitoring review must be performed, and it has proved that it has formulated adequate internal surveillance and procedures to fulfill the responsibilities under the listing rules.

- END -